cp wire

CP Wire Articles

EnteroBiotix, a leading clinical stage microbiome therapeutics company headquartered in Aberdeen, Scotland, has closed an oversubscribed seed extension investment and is set for international... read more

Wed, 05/29/19 - 09:16 am
admin

Fort Worth, TX May 28, 2019 — SOURCE EXPLORER, a life sciences supplier search and matching service, announced today that it has... read more

Tue, 05/28/19 - 10:22 am
admin

Microbiome Report for Week Ending 5/18/19

4D Pharma's Chron's Disease Treatment Meets Safety Objective
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on... read more

Sun, 05/26/19 - 02:28 pm
admin

Stoke Therapeutics filed for its IPO that could be worth up to $86 million. The Bedford, MA-based company is developing therapies to treat severe genetic diseases  by, “precisely protein... read more

Fri, 05/24/19 - 09:39 am
admin

Fountain Healthcare Partners (“Fountain”) announced on 5/23/19 the initial closing of its third fund, Fountain Healthcare Partners Fund III, L.P. (“Fund III”) with €118 million of committed... read more

Thu, 05/23/19 - 09:35 am
admin

NeoGenomics, Inc. (NASDAQ: NEO),  a leading provider of cancer-focused genetic testing services, announced on 5/22/19 the pricing of its underwritten public offering of 7,000,000 shares of its... read more

Wed, 05/22/19 - 09:31 am
admin

Sofinnova Partners, a European venture capital firm specializing in Life Sciences, announced today the launch of MD Start III, which closed above its original target of €40 million. With this new... read more

Tue, 05/21/19 - 10:10 am
admin

Guardant Health Filed for a public offering of up to 5,175,000 shares of common stock. At current prices this would raise $405 million+. Guardant trades on NASDAQ under the symbol, “GH.”

... read more

Tue, 05/21/19 - 09:46 am
admin

For an extended time, IBT has consulted with the US Food and Drug Administration (FDA) on how the company’s planned Phase III study should be designed. IBT announced on 5/19/19 that the FDA has... read more

Mon, 05/20/19 - 10:57 pm
admin

A National Leader in Healthcare Research Heads Operations and Delivery Team

Columbia, MD, May 20, 2019 – Health Analytics, LLC, a leading provider... read more

Mon, 05/20/19 - 09:53 am
admin

On 5/20/19 Syncona Ltd ("Syncona") announced the foundation of Quell Therapeutics (Quell), a new cell therapy company, with a £35 million ($43 million) commitment in a Series A financing of which... read more

Mon, 05/20/19 - 09:32 am
admin
Fri, 05/17/19 - 10:41 am
admin

Aeneas Capital Limited (“ACL”) and Pyrinas Real Estate Management Limited (“Pyrinas”), based in Hong Kong, announced on 5/16/19 that they are launching a US$120m innovative closed-ended property... read more

Thu, 05/16/19 - 09:34 am
admin

The company plans to offer 4,333,333 American Depositary Shares and raise a maximum $79,733,328. Bicycle has applied to trade trade on the NASDAQ Global Market under the symbol "BCYC."

... read more

Tue, 05/14/19 - 09:23 am
admin
Fri, 05/10/19 - 09:44 am
admin
Advances in oral insulin development bring promise of a better lifestyle for millions of Americans who rely on daily insulin injections 
 
New York, NY, May 9... read more
Thu, 05/9/19 - 01:03 pm
admin

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria,... read more

Tue, 05/7/19 - 11:28 pm
admin

Twist Bioscience (NASDAQ: TWIST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced on 5/6/19 that it has commenced... read more

Tue, 05/7/19 - 09:36 am
admin

Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, announced on 4/30/19 that data demonstrating its... read more

Thu, 05/2/19 - 11:51 am
admin

Pages



current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.